Main

related bits

0

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-02-13 13:19:39

expired found date

-

created at

2024-06-07 06:35:08

updated at

2025-12-30 11:16:37

Domain name statistics

length

15

crc

34730

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

14614569

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

12930

mp size raw text

1452

mp inner links count

2

mp inner links status

20 (imported)

Open Graph

title

description

image

site name

author

updated

2025-12-18 10:51:25

raw text

About | UCB Ventures Skip to main content UCB – Inspired by patients. Driven by science. UCB on Twitter UCB on LinkedIn UCB on Facebook UCB Worldwide Main navigation About Team Portfolio News Power, Precision & Agility Where to find us BRUSSELS LONDON BOSTON About UCB Ventures UCB Ventures is an evergreen strategic corporate venture fund established in 2017 to further strengthen UCB's ability to create value from novel insights and technologies that can transform the lives of patients suffering from severe diseases. We make long term investments in early stage companies in the US and Europe. Our portfolio reflects our investment strategy. We invest in start-ups developing novel therapeutic modalities and platforms/assets that address novel biology in areas adjacent to or even beyond UCB's current therapeutic focus. We are seeking breakthrough innovations in next-generation cell and gene therapy, regenerative medicine, cell a...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Medycyna (36)

index version

2025110801

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

1142

text words

205

text unique words

138

text lines

29

text sentences

12

text paragraphs

3

text words per sentence

17

text matched phrases

3

text matched dictionaries

3

RSS

rss status

12 (RSS import suspended due to XML file errors)

rss found date

2025-04-03 09:39:33

rss size orig

46962

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

30 (processing completed, results pushed to table crawler_sitemaps.ext_domain_sitemap_lists)

sitemap review version

1

sitemap urls count

1

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2024-02-22 10:20:02

sitemap process date

2025-01-20 08:31:48

sitemap first import date

-

sitemap last import date

-